Abstract
Emergomycosis is an invasive fungal disease caused by dimorphic fungi from the recently described Onyenalean genus, Emergomyces. The disease has been reported from four continents (Europe, Asia, Africa, and North America), although by far the most cases have been reported from South Africa. Nearly all affected patients have been profoundly immunocompromised, typically with a deficiency of cell-mediated immunity such as advanced HIV infection or immunosuppression for organ transplantation. The disease is typically disseminated at diagnosis, involving skin, lungs, and often bloodstream, although other sites may also be affected. In patients with HIV, an unmasking immune reconstitution inflammatory syndrome can occur in the form of new or worsening skin lesions after initiation of antiretroviral therapy. The histopathological picture is identical to histoplasmosis. The diagnosis can be secured by isolating the fungus in culture of biopsied tissue, blood, or other clinical specimens using standard fungal media, or sequencing of broad-range fungal targets (like internal transcribed spacer) from infected tissue. Treatment of severe disease involves induction with amphotericin B followed by itraconazole or newer azole for at least 1 year pending immune reconstitution.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schwartz IS, Govender NP, Sigler L, et al. Emergomyces: the global rise of new dimorphic fungal pathogens. PLoS Pathog. 2019;15(9):e1007977.
Gori S, Drouhet E, Gueho E, et al. Cutaneous disseminated mycosis in a patient with AIDS due to a new dimorphic fungus. J Mycol Med. 1998;8(2):57–63.
Drouhet E, Gueho E, Gori S, et al. Mycological, ultrastructural and experimental aspects of a new dimorphic fungus, Emmonsia pasteuriana sp. nov. isolated from a cutaneous disseminated mycosis in AIDS. J Mycol Med. 1998;8(2):64–77.
Borman AM, Jiang Y, Dukik K, Sigler L, Schwartz IS, de Hoog GS. Adiaspiromycosis and diseases caused by related fungi in Ajellomycetaceae. In: Seyedmousavi S, de Hoog GS, Guillot J, Verweij PE, editors. Emerging and epizootic fungal infections in animals. Cham: Springer International Publishing; 2018. p. 147–58.
Kenyon C, Bonorchis K, Corcoran C, et al. A dimorphic fungus causing disseminated infection in South Africa. N Engl J Med. 2013;369(15):1416–24.
Wellinghausen N, Kern WV, Haase G, et al. Chronic granulomatous lung infection caused by the dimorphic fungus Emmonsia sp. Int J Med Microbiol. 2003;293(6):441–5.
Wang P, Kenyon C, de Hoog S, et al. A novel dimorphic pathogen, Emergomyces orientalis (Onygenales), agent of disseminated infection. Mycoses. 2017;60(5):310–9.
Tang XH, Zhou H, Zhang XQ, Han JD, Gao Q. Cutaneous disseminated emmonsiosis due to Emmonsia pasteuriana in a patient with cytomegalovirus enteritis. JAMA Dermatol. 2015;151(11):1263–4.
Feng P, Yin S, Zhu G, et al. Disseminated infection caused by Emmonsia pasteuriana in a renal transplant recipient. J Dermatol. 2015;42(12):1179–82.
Schwartz IS, Kenyon C, Feng P, et al. 50 years of Emmonsia disease in humans: the dramatic emergence of a cluster of novel fungal pathogens. PLoS Pathog. 2015;11(11):e1005198.
Jiang YP, Dukik K, Munoz JF, et al. Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis. Fungal Divers. 2018;90(1):245–91.
Dukik K, Munoz JF, Jiang Y, et al. Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales). Mycoses. 2017;60(5):296–309.
Schwartz IS, Sanche S, Wiederhold NP, Patterson TF, Sigler L. Emergomyces canadensis, a dimorphic fungus causing fatal systemic human disease in North America. Emerg Infect Dis. 2018;24(4):758–61.
PelegrÃn I, Alastruey-Izquierdo A, Ayats J, Cuenca-Estrella M, Cabellos C. A second look at Emmonsia infection can make the difference. Transpl Infect Dis. 2014;16(3):519–20.
Lavergne R-A, Kandel-Aznar C, Khatchatourian L, et al. Emmonsia pasteuriana: une cause rare d’infection fongique chez l’immunodéprimé. J Mycol Med. 2017;27(3):e7–8.
Gast KB, van der Hoeven A, de Boer MGJ, et al. Two cases of Emergomyces pasteurianus infection in immunocompromised patients in The Netherlands. Med Mycol Case Rep. 2019;24:5.
Chik KK, To WK. Autochthonous Emergomyces pasteurianus pneumonia in an immunocompromised patient in Hong Kong: a case report. Hong Kong Med J. 2020;26(5):446–8.
Malik R, Capoor MR, Vanidassane I, et al. Disseminated Emmonsia pasteuriana infection in India: a case report and a review. Mycoses. 2016;59(2):127–32.
Capoor MR, Mishra N, Kolte S, et al. Disseminated Emergomyces pasteurianus infection in India: a case report and a review. Mycopathologia. 2020;185(1):193–200.
He D, Quan M, Zhong H, et al. Emergomyces orientalis Emergomycosis diagnosed by metagenomic next-generation sequencing. Emerg Infect Dis J. 2021;27(10):2740.
Schwartz IS, Kenyon C, Lehloenya R, et al. AIDS-related endemic mycoses in Western Cape, South Africa, and clinical mimics: a cross-sectional study of adults with advanced HIV and recent-onset, widespread skin lesions. Open Forum Infect Dis. 2017;4(4):ofx186.
Schwartz IS, Govender NP, Corcoran C, et al. Clinical characteristics, diagnosis, management and outcomes of disseminated emmonsiosis: a retrospective case series. Clin Infect Dis. 2015;61(6):1004–12.
Rooms I, Mugisha P, Gambichler T, et al. Disseminated Emergomycosis in a person with HIV infection, Uganda. Emerg Infect Dis. 2019;25(9):1750–1.
Bhagoobhai L, Seetharam S, Wadula J. Dimorphic fungus (Emmonsia species) isolated from sterile sites between March 2014 to April 2015. In: 6th FIDSSA Congress 2015: South African Journal of Infectious Diseases; 2015. p. 120–75.
Maphanga TG, Britz E, Zulu TG, et al. In vitro antifungal susceptibility of yeast and mold phases of isolates of dimorphic fungal pathogen Emergomyces africanus (formerly Emmonsia sp.) from HIV-infected South African patients. J Clin Microbiol. 2017;55(6):1812.
Lochan H, Naicker P, Maphanga T, et al. A case of emmonsiosis in an HIV-infected child. South Afr J HIV Med. 2015;16(1):352.
Maphanga TG, Naicker SD, Gómez BL, et al. Cross-reactivity of a Histoplasma capsulatum antigen enzyme immunoassay in urine specimens from persons with emergomycosis in South Africa. Med Mycol. 2020;59:672.
Kuzyk AC, Burbidge T, Mydlarski PR. Cutaneous Emmonsia infection in a renal transplant recipient. JAAD Case Rep. 2021;11:44–6.
Jiang Y, Tsui CKM, Ahmed SA, et al. Intraspecific diversity and taxonomy of Emmonsia crescens. Mycopathologia. 2020;185(4):613–27.
Schwartz IS, Lerm B, Hoving JC, et al. Emergomyces africanus in soil, South Africa. Emerg Infect Dis. 2018;24(2):377.
Schwartz IS, McLoud JD, Berman D, et al. Molecular detection of airborne Emergomyces africanus, a thermally dimorphic fungal pathogen, in Cape Town, South Africa. PLoS Negl Trop Dis. 2018;12(1):e0006174.
Cronjé N, Schwartz IS, Retief L, et al. Attempted molecular detection of the thermally dimorphic human fungal pathogen Emergomyces africanus in terrestrial small mammals in South Africa. Med Mycol. 2018;56(4):510–3.
Lerm B, Kenyon C, Schwartz IS, et al. First report of urease activity in the novel systemic fungal pathogen Emergomyces africanus: a comparison with the neurotrope Cryptococcus neoformans. FEMS Yeast Res. 2017;17(7).
Crombie K, Spengane Z, Locketz M, et al. Paradoxical worsening of Emergomyces africanus infection in an HIV-infected male on itraconazole and antiretroviral therapy. PLoS Negl Trop Dis. 2018;12(3):e0006173.
Mutyaba A, Sonderup MW, Locketz M, Okpechi I, Spearman CW, Tooke A. Disseminated Emmonsia in an HIV-HBV co-infected man. IDCases. 2015;2(2):35–6.
Govender NP, Grayson W. Emergomycosis (Emergomyces africanus) in advanced HIV disease. Dermatopathology. 2019;6(2):63–9.
Thompson GR III, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses. Lancet Infect Dis. 2021;21:e364.
Dukik K, Al-Hatmi AMS, Curfs-Breuker I, Faro D, De Hoog S, Meis JF. Antifungal susceptibility of emerging dimorphic pathogens in the family Ajellomycetaceae. Antimicrob Agents Chemother. 2018;62(1):e01886-17.
Further Reading
Jiang YP, Dukik K, Munoz JF, et al. Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis. Fungal Divers. 2018;90(1):245–91.
Schwartz IS, Govender NP, Sigler L, et al. Emergomyces: the global rise of new dimorphic fungal pathogens. PLoS Pathog. 2019;15(9):e1007977.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Schwartz, I.S. (2023). Emergomycosis. In: Hospenthal, D.R., Rinaldi, M.G., Walsh, T.J. (eds) Diagnosis and Treatment of Fungal Infections. Springer, Cham. https://doi.org/10.1007/978-3-031-35803-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-031-35803-6_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-35802-9
Online ISBN: 978-3-031-35803-6
eBook Packages: MedicineMedicine (R0)